Drain Removal Before Versus After CPM in Primary Total Knee Arthroplasty
Condition(s) studied
Investigational drug(s) / intervention(s)
Drain Removal Before CPM: Hemovac drain removal performed approximately 24 hours after primary TKA, immediately before a standardized 1-hour CPM session (0-90°). All other surgical, perioperative, and rehabilitation protocols are identical across study arms.
Drain Removal After CPM: A standardized 1-hour CPM session at 0-90° is administered approximately 24 hours after primary TKA. The hemovac drain is removed immediately after completion of the CPM session. All other surgical, perioperative, and rehabilitation protocols are identical across study arms.
Study summary
The aim of this prospective randomized controlled study was to determine whether the timing of drain removal in relation to continuous passive motion (CPM) application influences postoperative residual hematoma formation following primary total knee arthroplasty (TKA). Our primary hypothesis was that removing the drain after initiating CPM would result in less residual hematoma, as CPM-induced intra-articular fluid and blood mobilization would be evacuated through the drain before its removal, thereby reducing postoperative fluid accumulation.
Eligibility
Primary outcome measure(s)
- Residual Hematoma Formation — Preoperative; Postoperative Day 2; Day 14; Day 28
Residual hematoma formation assessed by knee circumference measurements at the level of the superior pole of the patella. Circumference is measured on both the operated and contralateral knees. The difference from baseline and between-group differences are evaluated.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ankara Etlik City Hospital | Ankara | Turkey (Türkiye) |
More Ankara Etlik City Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07302724 on ClinicalTrials.gov ↗ ← All trials in Turkey